Search

cobas® HCV Test

Product image for cobas® HCV Test

Innovative, dual-probe HCV viral load testing for the cobas® 4800 and cobas® 5800/6800/8800 Systems

Accurate quantification and detection for an ever-changing virus

 

Every day, approximately 4,000 people die from the consequences of viral hepatitis, and 1.4 million people every year1 Roche is committed to fighting viral hepatitis with effective diagnosis and monitoring. For hepatitis C, cobas® HCV for use on the cobas ® 4800 and cobas ® 5800/6800/8800 Systems, offers precise, dual-probe HCV viral load testing to accurately identify the disease and determine patient response to treatment.

See what truly matters when testing for HCV

A quantitative hepatitis C virus (HCV) RNA test must be able to tolerate sequence mismatches for accurate and reliable results. The combination of error-prone RNA replication and a high rate of virus production results in extreme genetic variability of HCV. Clinicians rely on regular HCV viral load assessment to achieve an optimal treatment outcome.

The cobas® HCV quantitative nucleic acid test delivers robust, clinically relevant assay performance based on the proprietary dual-probe assay design from Roche. cobas® HCV is designed to deliver high sensitivity to meet the requirements of current and future chronic hepatitis C therapies combined with an efficient workflow for laboratories.

The innovative, state-of-the-art dual-probe HCV viral load assay precisely distinguishes true signals from background noise leading to more accurate quantification of viral loads.

Features

  • Accurate detection and quantification of HCV genotypes 1 through 6
  • Clinically validated for use with new HCV therapies
  • Excellent correlation with the COBAS® AmpliPrep / COBAS® TaqMan® HCV Quantitative Test, v2.0

Optimised clinical decisions through precise HCV viral load assessment

  • Accurate HCV RNA viral load results are important for monitoring patients treated with the DAAs to decide on continuation of therapy and assess treatment success
  • The Roche HCV dual-probe assay helps clinicians to better manage HCV patients facilitating optimised clinical decision
Intended use

Intended use

cobas® HCV is an in vitro nucleic acid amplification test for both the detection and quantitation of hepatitis C virus (HCV) RNA, in human EDTA plasma or serum, of HCV-infected individuals. Samples containing HCV genotype 1 to 6 are validated for detection and quantitation in the assay. 

The test is intended for use as an aid in the diagnosis of HCV infection in the following populations: individuals with antibody evidence of HCV with evidence of liver disease, individuals suspected to be actively infected with HCV antibody evidence, and individuals at risk for HCV infection with antibodies to HCV. Detection of HCV RNA indicates that the virus is replicating and therefore is evidence of active infection. The test is intended for use as an aid in the management of HCV-infected patients undergoing anti-viral therapy. The assay measures HCV RNA levels at baseline and during treatment and can be utilized to predict sustained and non-sustained virological response to HCV therapy. The results must be interpreted within the context of all relevant clinical and laboratory finding.  

 

These are the intended use for the cobas HBV assay on the different platforms

 

cobas® HCV is an in vitro nucleic acid amplification test for both the detection and quantitation of hepatitis C (HCV) RNA, genotypes 1 to 6, in human EDTA plasma or serum of HCV-infected individuals.   

cobas® HCV is intended for use as an aid in the diagnosis of HCV infection in the following populations: individuals with antibody evidence of HCV with evidence of liver disease, individuals suspected to be actively infected with HCV antibody evidence, and individuals at risk for HCV infection with antibodies to HCV. Detection of HCV RNA indicates that the virus is replicating and therefore is evidence of active infection. The test is intended for use in the management of patients with chronic HCV in conjunction with clinical and laboratory markers of infection. The test can be used to predict the probability of sustained virologic response (SVR) early during a course of antiviral therapy, and to assess viral response to antiviral treatment (response guided therapy) as measured by changes of HCV RNA levels in serum or EDTA plasma. The results must be interpreted within the context of all relevant clinical and laboratory findings.   

Registration status

cobas® HCV for 4800 System: CE-IVD 

cobas® HCV for 5800/6800/8800 Systems: CE-IVD

 

Package inserts

Access package inserts through your Roche DiaLog.

 

Related diseases

Reference

 

  1. World Health Organization (WHO). World Hepatitis Day.
     http://www.who.int/campaigns/hepatitis-day/2016/event/en. Accessed July 2016. 
Contact Us

Related information

cobas® 4800 System Performance

  • Sample type

    EDTA plasma, serum

  • Sample processing volume

    400 µL or 200 µL

  • Analytical sensitivity

    9.2 lU/mL (400 µL)
    15.3 lU/mL (200 µL)

  • Linear range

    400 µL: 15 lU/mL - 1.0E+08 IU/mL
    200 µL: 25 lU/mL - 1.0E+08 IU/mL

  • Specificity

    99.5% (one-sided 95% confidence interval: 98.7%)

  • Genotypes detected

    HCV genotypes 1-6

cobas® 5800/6800/8800 Systems Performance

  • Sample type

    EDTA plasma, serum

  • Minimum amount of sample required

    650µL or 350µL

  • Sample processing volume

    500µL or 200µL

  • Analytical sensitivity

    15 lU/mL (500 µL)
    40 lU/mL (200 µL)

     

  • Linear range

    500 µL: 15 lU/mL - 1.0E+08 IU/mL
    200 µL: 40 lU/mL - 1.0E+08 IU/mL

  • Specificity

    100% (one-sided 95% confidence interval: 99.5%

  • Genotypes detected

    HCV genotypes 1-6

Related assays

Country Specific Labeling See country-specific product labeling for regulatory status.
LightCycler<sup>®</sup> 96 Instrument
LightCycler® 96 Instrument The LightCycler® 96 Instrument is a real-time PCR system for rapid cycling up to 96 samples. Applications include absolute and relative quantification, qualitative detection, melting curve analysis, high resolution melting and endpoint genotyping. Precise LightCycler® 96 Instrument thermal homogeneity and cycling speed produce accurate and reproducible results in a very short time. The LightCycler® 96 Instrument's optical detection system flexibly detects sequence-dependent probes, such as hydrolysis probes and sequence-independent dyes (i.e., SYBR Green I). Multiplex and multicolor capabilities permit the use of up to four different fluorescent dyes. New innovative LightCycler® 96 Application and Instrument Software creates a simple analysis workflow with easy import and export functions, email notifications after each run, online monitoring flexibility, and server-based network interfacing.
IVD For in vitro diagnostic use.
MagNA Pure 96 Instrument
MagNA Pure 96 Instrument High-throughput robotic workstation for fully automated purification of nucleic acids from up to 96 samples. Magnetism is the underlying principle of the automated nucleic acid isolation performed by the highthroughput MagNA Pure 96 System. The MagNA Pure 96 Instrument performs automated nucleic acid purification from samples of up to 1000 μl that are pipetted into a 96-well processing cartridge. It comprisesa magnetic glass particles (MGP) based purification process as well as protocols that support isolation of RNA, DNA and tNA from different sample materials. The MagNA Pure 96 System permits automated nucleic acid purification that matches the high standards of speed, accuracy and reliability in PCR/ RT-PCR of the LightCycler® Systems.
IVD For in vitro diagnostic use.
MagNA Pure 24 Instrument
MagNA Pure 24 Instrument A fully-automated clinical nucleic acid extraction system that brings you walkaway automation for up to 24 samples. The MagNA Pure 24 System is a fully automated clinical sample extractor. It extracts nucleic acids from various sample types, sample tubes, and volume inputs for multiple downstream applications.The main features of the system are:Scalable purification of 1 to 24 samplesPrimary/secondary tube handlingInventory and sample management via barcodesEfficient order management via host
IVD For in vitro diagnostic use.
cobas® 6800 System
cobas® 6800 System Embrace the future of molecular testing with proven PCR performance. Learn about the cobas® 6800 System’s broad menu of high-quality assays, including HIV, HPV, CT/NG, Hepatitis, CMV, WNV, respiratory infections, and more!
cobas® SARS-CoV-2 test kit
cobas® SARS-CoV-2 Test
IVD For in vitro diagnostic use.
<b>ePlex<sup>®</sup></b> 6-bay system
ePlex® system The ePlex system is used to run multiplex microarray-based assays developed by GenMark. This type of assay is based on the principles of competitive nucleic acid hybridization using a sandwich assay format, wherein a single-stranded target binds concurrently to a sequence-specific solution-phase signal probe and a solid-phase electrode-bound capture probe. The test employs nucleic acid extraction, target amplification via polymerase chain reaction (PCR) or reverse transcription PCR (RT-PCR) and hybridization of target DNA. In the process, the double-stranded PCR amplicons are digested with exonuclease to generate single-stranded DNA suitable for hybridization.
IVD For in vitro diagnostic use.
cobas® 8800 System
cobas® 8800 System Run up to 1,056 tests in an 8-hour shift and experience unparalleled automation - only 3 user interactions per run for up to 4 hours of walk-away time.
IVD For in vitro diagnostic use.
cobas® 5800 System
cobas® 5800 System The cobas® 5800 System makes automation, consolidation, integration and standardization more accessible than ever before.
IVD For in vitro diagnostic use.
digital lightcycler product thumbnail
Digital LightCycler® System Unleash the true power of digital PCR
IVD For in vitro diagnostic use.
<b>cobas</b><sup>®</sup> <b>liat</b> system
cobas® liat system The cobas® liat analyzer is an automated nucleic acid test instrument, that when used together with cobas® liat assay tubes to perform in vitro diagnostic tests, is referred to as the cobas® liat system. In conjunction with a cobas® liat assay tube, the instrument performs reagent preparation, target enrichment, inhibitor removal, nucleic acid extraction, polymerase chain reaction (PCR) amplification, real-time detection, and result interpretation to automate the detection or quantification of nucleic acid targets in a biological sample.Addition for Canada only:The cobas® liat system is intended for professional use in a clinical laboratory setting or Point of Care (POC) location.
IVD For in vitro diagnostic use.
<b>cobas<sup>®</sup> prime</b> pre-analytical system
cobas® prime pre-analytical system Content was migrated to RDK.

Related systems

cobas® 4800 System image

cobas® 4800 System

Highly efficient, flexible workflows and a consolidated assay menu deliver confidence with every result. Automated PCR setup and analysis help make the most of your resources and reduce error.

More
cobas® 6800 System image

cobas® 6800 System

Transform your testing experience for IVD applications—just 2 simple user interactions per run and up to 8 hours of walk-away time.

More
cobas® 8800 System image

cobas® 8800 System

Unparalleled performance with minimal operator interaction revolutionises the future of high-throughput applications. 

More